[研究报告] CIN 及 HR-HPV 治疗市场规模预计将从 2022 年的 116.3517 亿美元增至 2028 年的 171.6461 亿美元;预计 2023 年至 2028 年市场复合年增长率为 6.7%。
CIN 和 HR-HPV 治疗市场根据疾病类型、菌株类型、产品、产品类型、最终用户和地理位置进行细分。该报告提供了对市场的深入分析和见解,强调了市场中的驱动因素、趋势和机会等参数,以及各地区主要市场参与者的竞争格局分析。它还包括对 COVID-19 大流行对各主要地区影响的分析。
市场洞察
预防宫颈癌的有利举措推动 CIN 和 HR-HPV 治疗市场增长
2020 年 8 月,世界卫生组织 (WHO) 制定了一项消除宫颈癌的全球战略。根据这一战略,世界各国必须致力于达到并维持每 100,000 名女性中不到 4 人的发病率,以消除宫颈癌。为了实现如此低的发病率,各国应专注于 宫颈癌筛查、治疗和疫苗接种。医疗保险是一项受欢迎的政府保险计划,它为每两年进行的宫颈癌筛查的 PAP 检查、盆腔检查和临床乳房检查提供保险。
国际药品援助组织 (Unitaid) 是一家全球卫生机构,致力于为中低收入国家提供预防、诊断和治疗主要疾病的创新解决方案,该组织提出了一项预防宫颈癌的新计划。其工作重点是扩大关键工具和服务的可及性,以筛查宫颈癌的早期迹象,然后治疗阳性病例。国际药品援助组织正在为克林顿健康获取倡议 (CHAI) 和扩大宫颈癌消除与二级预防战略 (SUCCESS) 项目提供支持,这些项目正在与 Expertise France、Jhpiego 和国际抗癌联盟 (UICC) 合作开展。国际药品援助组织正在与这些合作伙伴以及 14 个中低收入国家的政府合作,开发一套经济实惠且高效的工具包,以帮助世界卫生组织实现其宫颈癌消除目标。国际药品援助组织已投资约 7000 万美元用于创新工具,以筛查生活在资源匮乏环境中的女性的癌前病变并进行治疗。在14个国家,国际药品采购机制正在努力克服获取药品的障碍,为国家消除宫颈癌工作奠定基础,并为中低收入国家展示有效的预防模式。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
CIN 和 HR-HPV 治疗市场:
复合年增长率(2022 - 2028)6.7%- 2022 年市场规模
116.4 亿美元 - 2028 年市场规模
171.6 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 富士瑞比欧欧洲有限公司
- 凯杰公司
- 济利科有限公司
- 雅培实验室
- 造父变星
- F. 霍夫曼-罗氏有限公司
- INOVIO 制药公司
- 比奥尼尔公司
- Antiva 生物科学公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 宫颈上皮内瘤变 1
- 宫颈上皮内瘤变 2
- 宫颈上皮内瘤变 3
- HPV 16
- HPV 18
- 其他的
- 诊断方法和治疗方法
- 试剂盒和试剂
- 仪器
- 服务
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
在印度,根据资源可用性和合规标准,在各种环境中采用细胞学、联合检测(HPV + 细胞学)、初级 HPV 检测和醋酸目视检查等筛查方法。印度妇产科医师联合会 (FOGSI) 已发布良好临床实践建议 (GCPR),用于管理不同资源环境中的筛查阳性女性。RMNCH + A(代表生殖孕产妇新生儿儿童健康 + 青少年健康 + 青少年)是印度国家卫生使命 (NHM) 的战略,鼓励小家庭规范。该战略包括由认证社会健康活动家 (ASHA) 在家中提供避孕药具、推迟结婚年龄、促进月经卫生和性卫生意识,以及促进在“Suraksha 诊所”治疗生殖道疾病。
各医疗机构和政府为预防宫颈癌而采取的此类举措促进了 CIN 和 HR-HPV 治疗市场的增长。
基于疾病类型的见解
根据疾病类型,CIN 和 HR-HPV 治疗市场细分为宫颈上皮内瘤变 1 (CIN 1)、宫颈上皮内瘤变 2 (CIN 2) 和宫颈上皮内瘤变 3 (CIN 3)。2022 年,宫颈上皮内瘤变 3 (CIN 3) 细分市场占据最大市场份额,预计在预测期内将录得最高复合年增长率。
基于菌株类型的见解
根据菌株类型,CIN 和 HR-HPV 治疗市场细分为 HPV 16、HPV 18 和其他。HPV 16 细分市场在 2022 年占据了最大的市场份额。HPV 18 细分市场预计将在预测期内录得最高复合年增长率。
基于产品的洞察
根据产品,CIN 和 HR-HPV 治疗市场分为诊断方法和治疗。2022 年,治疗部分占据了更大的市场份额。然而,诊断方法部分预计在预测期内将实现更高的复合年增长率。此外,诊断方法部分进一步分为 HPV 检测、巴氏涂片检查、阴道镜检查和活检。2022 年,HPV 检测部分在诊断方法市场上占有最大份额。此外,治疗部分分为切除手术和消融技术。2022 年,消融技术部分占据了更大的市场份额,预计在预测期内将在市场上实现更高的复合年增长率。
基于产品类型的洞察
根据产品类型,CIN 和 HR-HPV 治疗市场分为试剂盒和试剂、仪器和服务。服务部门在 2022 年占据了最大的市场份额,预计在预测期内将录得最高的复合年增长率。
基于最终用户的洞察
根据最终用户,CIN 和 HR-HPV 治疗市场分为医院和诊所、诊断实验室、专业临床实验室和其他。医院和诊所部门在 2022 年占据了最大的市场份额。诊断实验室部门预计在预测期内将录得最高的复合年增长率。
CIN 和 HR-HPV 治疗市场参与者采用产品发布和扩张等有机策略来扩大其地理覆盖范围和产品组合。此外,这些增长策略有助于公司加强客户群并扩大其产品组合。
- 2022 年 10 月,Fujirebio Europe 与 Self-screen BV 建立了商业合作关系,以分销 PreCursor-M+ 甲基化特异性分子体外诊断 (IVD) 检测(Self-screen BV 的商标)。该检测旨在定性检测宫颈癌生物标志物的甲基化水平升高。它可用作 HPV 阳性结果和 ASCUS/LSIL 细胞学检查女性的分诊随访检测。PreCursor-M+ 检测完善了 Fujirebio 的 HPV 特异性分子检测产品组合。
- 2021 年 4 月,罗氏公司获得美国 FDA 批准,将全自动、高通量 cobas 6800/8800 系统用于 HPV 检测。cobas HPV 检测通过检测宫颈样本中 hrHPV DNA 的存在来识别有宫颈癌风险的女性。cobas HPV 适用于根据专业医疗指南进行常规宫颈癌筛查,包括 ASC-US 细胞学分类和女性的初级 HPV 筛查,以评估宫颈癌前病变和癌症的风险。
CIN 和 HR-HPV 治疗市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 116.4亿美元 |
2028 年市场规模 | 171.6亿美元 |
全球复合年增长率(2022 - 2028) | 6.7% |
历史数据 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按疾病类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
公司简介
- 富士瑞比欧欧洲有限公司
- 凯杰公司
- 济利科有限公司
- 雅培实验室
- 造父变星
- F. 霍夫曼-罗氏有限公司
- INOVIO 制药公司
- 比奥尼尔公司
- Antiva 生物科学公司
- 赛默飞世尔科技公司
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Key factors that are driving the growth of this market are Increase in prevalence of human papillomavirus infections and favorable Initiatives for preventing cervical cancer.
High-risk HPV is associated with cervical intraepithelial neoplasia (CIN). Persistent infection with high-risk human papillomavirus (HPV) results in invasive cervical cancer. Also, HR-HPV subtypes particularly HPV 16 and HPV 18 causes cervical cancer. The main aim of NHS Cervical Screening Program (NHS CSP) is to reduce the incidence and mortality from cervical cancer through a systematic, quality-assured population-based screening program for people aged 24 to 64.
Cervical Intraepithelial Neoplasia 3 segment held the largest share of the market in the global CIN and HR-HPV Treatment Market and held the largest market share of 47.48% in 2022.
The CAGR value of the CIN and HR-HPV Treatment Market during the forecasted period of 2022-2028 is 6.7%.
The hospitals & clinics segment dominated the global CIN and HR-HPV Treatment Market and held the largest market share in 2021.
Global CIN and HR-HPV Treatment Market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the CIN and HR-HPV Treatment Market in 2021. With several North American market players focusing on research and development activities, the regional market for CIN and HR-HPV Treatment Market is likely to propel in North America region during the forecast period.
Abbott and Cepheid are the top two companies that hold huge market shares in the CIN & HR-HPV Treatment Market.
The CIN and HR-HPV Treatment Market majorly consists of the players such Fujirebio Europe NV, Qiagen NV, Zilico Ltd, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, INOVIO Pharmaceuticals Inc, Bioneer Corp, Antiva Biosciences Inc, and Thermo Fisher Scientific Inc.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - CIN & HR-HPV Treatment Market
- Fujirebio Europe NV
- Qiagen NV
- Zilico Ltd
- Abbott Laboratories
- Cepheid
- F. Hoffmann-La Roche Ltd
- INOVIO Pharmaceuticals Inc
- Bioneer Corp
- Antiva Biosciences Inc
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.